Major trial tests if early chemo boosts survival for advanced prostate cancer
Disease control
Completed
This large, completed study aimed to see if adding chemotherapy (docetaxel) to standard hormone-blocking therapy could help men with prostate cancer that had spread to other parts of the body. It involved 790 men and directly compared the combination treatment against hormone the…
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC